Condensed Consolidated Statements Of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities
Net income	$ 47.7	$ 26.9
Loss (gain) disposal of assets	0.6	(2.3)
Release of tax valuation allowance	0	(7.0)
Depreciation	26.8	30.4
Other non-cash charges	0.6	0.9
Amortization of debt issuance costs	2.9	4.3
Amortization of intangibles	16.9	18.7
Stock-based compensation	11.6	11.7
Loss on debt extinguishment	0	9.4
Equity in earnings of joint ventures, net of dividends received	(0.4)	(0.9)
Changes in balance sheet items:
Accounts receivable	72.3	85.5
Inventories	(37.5)	(30.9)
Other assets	(10.1)	(5.8)
Accounts payable	(23.2)	20.7
Accrued expenses and other liabilities	(49.0)	(27.3)
Accrued income taxes	8.3	(9.1)
Net cash provided by operating activities	67.5	125.2
Investing activities
Additions to property, plant and equipment	(21.1)	(30.2)
Payments related to the sale of discontinued operations	0	(1.4)
Proceeds from the disposition of assets	3.8	4.2
Net cash (used) provided by investing activities	(17.3)	(27.4)
Financing activities
Proceeds from long-term borrowings	0	530.0
Repayments of long-term debt	(25.1)	(601.5)
Borrowings of notes payable, net	0.8	1.1
Payments for debt issuance costs	(0.3)	(4.3)
Repurchase of common stock	(2.9)	0
Other	(1.9)	(0.6)
Net cash used by financing activities	(29.4)	(75.3)
Effect of foreign exchange rate changes on cash and cash equivalents	(1.8)	(1.7)
Net increase in cash and cash equivalents	19.0	20.8
Cash and cash equivalents
Beginning of the period	53.5	50.0
End of the period	$ 72.5	$ 70.8